Article
A Scalable System for Production of Functional Pancreatic Progenitors from Human Embryonic Stem Cells
18 May 2012
Abstract excerpt
Development of a human embryonic stem cell (hESC)-based therapy for type 1 diabetes will require the translation of proof-of-principle concepts into a scalable, controlled, and regulated cell manufacturing process. We have previously demonstrated that hESC can be directed to differentiate into pancreatic progenitors that mature into functional glucose-responsive, insulin-secreting cells in vivo. In this study we...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
